Group | Baseline | Post-treatment | Within-group mean changes | Between-groups mean changes |
---|---|---|---|---|
LEFS, points | ||||
Control | 48 ± 17.1 | 50 ± 17.0 | 2 (1 to 4) | 20.0 (10 to 29) †† |
WBV | 53 ± 21.3 | 70 ± 16.0 | 17 (13 to 20) ** | |
KUJALA, points | ||||
Control | 52 ± 15.1 | 52 ± 13.0 | 0 (−3 to 3) * | 19.0 (10 to 27) †† |
WBV | 50 ± 23.4 | 71 ± 15.6 | 21 (14 to 28)** | |
DN4, points | ||||
Control | 3.4 ± 1.5 | 2.1 ± 1.2 | 1.3 (0.9 to 1.6) ** | 1.9 (1.3 to 2.4) †† |
WBV | 4.2 ± 2.1 | 0.2 ± .5 | 4 (3.1 to 4.9) ** | |
VAS, mm | ||||
Control | 59 ± 13.6 | 54 ± 14.1 | 5 (2 to 9)* | 44.0 (35 to 52)†† |
WBV | 56 ± 20.2 | 10 ± 15.4 | 46 (37 to 55)** | |
KNEE ROMFLEX,(°) | ||||
Control | 115 ± 10.9 | 110 ± 13.2 | 5 (0 to − 7)* | 23.0 (16 to 28)†† |
WBV | 120 ± 12.0 | 133 ± 7.3 | 13 (9 to 15)** | |
KNEE ROMEXT (°) | ||||
Control | 0.4 ± 1.4 | 0.2 ± 1 | 0.2 (− 0.2 to 0.6) | 0.2 (−0.5 to 0.9) |
WBV | 1 ± 2 | 0.4 ± 1.4 | 0.6 (− 0.08 to 1.3) |